The latest Investing Matters Podcast episode with Inclusive Asset Management's Alexandra McGuigan has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPennant International Regulatory News (PEN)

Share Price Information for Pennant International (PEN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 30.50
Bid: 30.00
Ask: 31.00
Change: 0.00 (0.00%)
Spread: 1.00 (3.333%)
Open: 30.50
High: 30.50
Low: 30.50
Prev. Close: 30.50
PEN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Placing

29 Jan 2019 12:45

RNS Number : 4297O
Pennant International Group PLC
29 January 2019
 

For immediate release

 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

 

Pennant International Group plc

("Pennant", the "Company" or the "Group") 

 

Results of the Placing

 

Further to the accelerated bookbuilding process announced earlier today, Pennant International Group plc is pleased to announce the results of an oversubscribed placing with institutional investors of 2,281,110 Placing Shares, comprising 1,647,160 Fundraising Shares and 633,950 Available Option Shares. The Placing was conducted at a price of 110 pence per Placing Share. The Placing Price represents a discount of 3.93 per cent. to the closing price on 28 January 2019, the last trading day prior to this announcement.

 

The gross proceeds of the Fundraising amounting to £1.8 million (before expenses) together with the proceeds of the exercise of the 690,000 share options amounting to approximately £331,525 will predominantly be used to fund the potential Acquisition and to facilitate further new product development, as detailed in the Company's earlier announcement today. A further announcement will be made about the Acquisition in due course.

 

Application for admission to trading on AIM for 2,337,160 New Ordinary Shares (comprising 1,647,160 Fundraising Shares and 690,000 Option Shares) being issued pursuant to the Fundraising and the exercise of share options has been made and Admission is expected to take place on 1 February 2019. The New Ordinary Shares will rank pari passu with the Existing Ordinary Shares in issue. The New Ordinary Shares will represent approximately 6.48 per cent. of the Enlarged Issued Share Capital on Admission (assuming no other issuance of ordinary shares prior to Admission).

 

In accordance with the provisions of the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority, the Company confirms that, following the issue of the New Ordinary Shares, its issued share capital will comprise 36,040,693 Ordinary Shares of 5 pence each. All of these Ordinary Shares have equal voting rights and none of the Ordinary Shares are held in Treasury. The total number of voting rights in the Company will therefore be 36,040,693 on Admission.

 

Pennant's Chief Executive Officer, Phil Walker, said: "We are delighted by the support we have received for this fundraising which will enable us to accelerate our Group strategy of increasing both commercial and recurring revenues through the planned Acquisition and further investment in innovative new products."

 

Terms used in this Announcement shall have the meanings given to such terms in the definitions section of the appendix to the announcement made by the Company at 7.00 a.m. this morning.

This announcement includes inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014 and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

Enquiries:

 

 

Pennant International Group plc

 

Simon Moore (Chairman)

+44 (0) 1452 714914

Philip Walker (Chief Executive Officer)

+44 (0) 1452 714914

 

 

WH Ireland Limited (Nominated Adviser and Broker)

 

Mike Coe / Chris Savidge (Corporate Finance)

+44 (0) 117 945 3470

Jasper Berry / Adam Pollock (Corporate Broking)

+44 (0) 207 220 1666

 

 

Walbrook PR (Financial PR)

paul.vann@walbrookpr.com

Paul Vann / Tom Cooper

+44 (0) 207 933 8780

+44 (0) 776 880 7631

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ROILKLFLKFFZBBX
Date   Source Headline
7th Feb 20247:00 amRNSAppointment of Non-executive Director
7th Feb 20247:00 amRNSYear-End Trading Update
22nd Nov 202311:41 amRNSHolding(s) in Company
15th Nov 20235:20 pmRNSHolding(s) in Company
27th Sep 20237:00 amRNS2023 Interim Results
11th Sep 20237:00 amRNSNew Strategic Partnership
7th Sep 20237:00 amRNSPennant attending DSEI, London
19th Jul 20237:00 amRNSTrading Update & Notice of Interim Results
10th Jul 202310:39 amRNSIssue of Equity, Director Dealings & TVR
13th Jun 20237:00 amRNSBusiness Update: New Contract Wins
7th Jun 202310:40 amRNSResult of AGM
23rd May 202310:45 amRNSHolding in Company
22nd May 20233:15 pmRNSHolding in Company
16th May 202312:21 pmRNSHolding in Company
27th Apr 202311:31 amRNSNotice of AGM & Posting of 2022 Annual Accounts
26th Apr 20237:00 amRNS2022 Final Results
20th Apr 20237:00 amRNSNotice of 2022 Final Results
13th Apr 20237:00 amRNSAcquisition of UK Rail Services Business
16th Mar 20232:00 pmRNSHolding(s) in Company
14th Mar 20235:30 pmRNSHolding(s) in Company
23rd Feb 20231:13 pmRNSAppointment of Chair
8th Feb 202311:05 amRNSSecond Price Monitoring Extn
8th Feb 202311:00 amRNSPrice Monitoring Extension
8th Feb 20237:00 amRNSYear-end Trading Update
19th Jan 20239:31 amRNSHolding(s) in Company
12th Jan 202312:47 pmRNSAppointment of Director
9th Nov 20227:00 amRNSShare Option Restructuring
24th Oct 20228:31 amRNSDirectorate Change
21st Sep 20227:00 amRNS2022 Interim Results
9th Aug 20225:51 pmRNSIssue of Equity, Director/PDMR Dealings & TVR
9th Aug 202210:32 amRNSHoldings in Company
3rd Aug 20227:00 amRNSSale of Pennant Court
28th Jul 20227:00 amRNSTrading Update & Notice of Interim Results
30th Jun 20227:00 amRNSNotice of Capital Markets Day
22nd Jun 202210:27 amRNSResult of AGM
27th May 202210:56 amRNSNotice of AGM
25th May 20227:00 amRNS2021 Final Results
29th Apr 20227:00 amRNSNotice of Final Results
19th Apr 20221:42 pmRNSHolding in Company
6th Apr 20227:00 amRNSIssue of Equity, Director/PDMR Dealings & TVR
23rd Mar 20227:00 amRNSContracts & Order Book Update
21st Jan 202210:19 amRNSMajor Programme Update
20th Jan 20229:05 amRNSSecond Price Monitoring Extn
20th Jan 20229:00 amRNSPrice Monitoring Extension
20th Jan 20227:00 amRNSTrading Update
16th Dec 202110:55 amRNSHolding in Company
3rd Dec 202111:20 amRNSMajor Programme Update
17th Nov 202112:04 pmRNSHolding in Company
11th Nov 20215:13 pmRNSDirectorate Change
1st Nov 20211:23 pmRNSHolding in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.